PDA signs on as Premier Association Sponsor for tenth year.
BETHESDA, Md., Jan. 10, 2023 /PRNewswire-PRWeb/ -- The Parenteral Drug Association, Inc. (PDA) and RX Global today announced the renewal of their Premier Association Sponsorship agreement for INTERPHEX 2023, taking place April 25-27, 2023, at the Javits Center in New York City. This is the tenth year PDA has served as a Premier Association Supporter.
PDA is a leading provider of science, technology and regulatory information and education, and INTERPHEX offers access to the very latest in technical sessions, cutting-edge development and manufacturing technologies and innovation to cost effectively and efficiently develop and manufacture quality product.
"Since 2014, PDA's Sponsorship of INTERPHEX reflects the association's interest in the continual enhancement of industry learning and improvement, areas we find present at INTERPHEX," stated Richard Johnson, President and CEO of PDA. "Our collaboration with INTERPHEX is one example of PDA's endeavors to help our members improve their operations based on the latest science and technology to develop safe and effective medicines for patients around the world."
"Our long-term collaboration with PDA has aligned INTERPHEX with thought leaders across the globe," stated Douglas Lugo, Event Director of INTERPHEX. "Through this partnership, we are able to expand the INTERPHEX audience and deliver even more exciting content and professional development opportunities at the Show."
Under the 2023 sponsorship agreement, PDA is developing a set of training courses for attendees of INTERPHEX.
###
Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation, so members can better serve patients. Go to http://www.pda.org/footer/about-pda to learn more.
INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can "Experience Science through Commercialization." The event is based in New York and brings approximately 8,000 global industry professionals and industry leading suppliers together to "Learn it, Experience it, Procure it" through a unique combination of exhibits, demonstrations, partnering opportunities, networking and no cost technical conference to leverage quality, efficiency, and cost effectiveness in today's ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. INTERPHEX and INNOPHEX together, offer the very latest intelligence cutting-edge technologies. and state-of-the-art innovation throughout the product development life cycle. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and Twitter. INTERPHEX continues the learning beyond the show floor. For more information, visit http://www.INTERPHEX.com
RX is in the business of building businesses for individuals, communities, and organizations. We elevate the power of face-to-face events by combining data and digital products to help customers learn about markets, source products, and complete transactions at over 400 events in 22 countries and regions across 43 industry sectors. RX is passionate about making a positive impact on society and is fully committed to creating an inclusive work environment for all our people. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. http://www.rxglobal.com
Media Contact
Walter Morris, www.pda.org, 1 3016565900, [email protected]
SOURCE www.pda.org
Share this article